METHYLENE BLUE injection, USP (Xiromed) – prescribing information (2026)

Government Record · Xiromed, LLC / U.S. National Library of Medicine DailyMed · May 2026

Xiromed et al., 2026-05: A second current US methylene blue label. It caps treatment at 1 mg/kg with one repeat of up to 1 mg/kg, i.e. a maximum of about 2 mg/kg, which is below the 3 to 4 mg/kg the seller calls the acute upper limit.

If methemoglobin level remains above 30% or if clinical symptoms persist, give a repeat dose of up to 1 mg/kg one hour after the first dose.

Xiromed et al., 2026-05: A second current US methylene blue label. It caps treatment at 1 mg/kg with one repeat of up to 1 mg/kg, i.e. a maximum of about 2 mg/kg, which is below the 3 to 4 mg/kg the seller calls the acute upper limit. Label, record field. Indication: acquired methemoglobinemia only. The 3-4 mg/kg figure the seller gives as 'typically the range given as an IV antidote for methemoglobinemia' does not appear on either current US label (compare MTR-008). Study type: regulatory record.